Edition:
United States

Fresenius SE & Co KGaA (FREG.DE)

FREG.DE on Xetra

73.19EUR
11:35am EDT
Change (% chg)

€-0.62 (-0.84%)
Prev Close
€73.81
Open
€73.23
Day's High
€73.45
Day's Low
€72.88
Volume
929,009
Avg. Vol
1,031,918
52-wk High
€77.45
52-wk Low
€60.00

Latest Key Developments (Source: Significant Developments)

Fresenius FY 2016 sales up 5 pct at 29.1 billion euros
Wednesday, 22 Feb 2017 01:14am EST 

Fresenius SE : FY sales 29.1 billion euros ($30.68 billion) (+5 pct, +6 pct in constant currency) . FY EBIT 4,327 million euros (+9 pct, +10 pct in constant currency), net income 1,593 million euros (+12 pct, +13 pct in constant currency) . Dividend proposal +13 pct to 0.62 euros per share . Q4 sales 7.7 billion euros (+7 pct, +6 pct in constant currency) . Outlook 2017: sales growth of 15 pct to 17 pct in constant currency, net income growth of 17 pct to 20 pct in constant currency .Targets 2020: group sales: between 43 billion euros and 47 billion euros, group net income: between 2.4 billion euros and 2.7 billion euros.  Full Article

Fresenius sets initial conversion price of €500 million convertible bonds
Thursday, 2 Feb 2017 01:04pm EST 

Fresenius Se & Co Kgaa : Fresenius says initial conversion price of €500 million equity-neutral convertible bonds due 2024 has been determined to be €107.0979 Further company coverage: [FREG.DE] ((frankfurt.newsroom@thomsonreuters.com; +49 69 7565 1270;)).  Full Article

Fresenius says Quironsalud to be consolidated as of Feb. 1
Tuesday, 31 Jan 2017 10:27am EST 

Fresenius SE : Says closes acquisition of Quironsalud . Says Quironsalud will be consolidated as of February 1, 2017 . Says 400 million eur balance of purchase price was paid in the form of 6.1 million new Fresenius shares issued today Further company coverage: [FREG.DE] ((frankfurt.newsroom@thomsonreuters.com; +49 69 7565 1270;)).  Full Article

Fresenius says placed 500 mln eur in convertible bonds
Thursday, 19 Jan 2017 11:40am EST 

Fresenius Se & Co Kgaa : Fresenius says placed €500 million equity-neutral convertible bonds due 2024 . Fresenius says issue price was fixed at 101.00% of the nominal value, corresponding to an annual yield to maturity of -0.142%d Further company coverage: [FREG.DE] ((frankfurt.newsroom@thomsonreuters.com; +49 69 7565 1270;)).  Full Article

Fresenius SE to issue 500 mln eur convertible bonds
Thursday, 19 Jan 2017 01:49am EST 

Fresenius SE & Co. KGaA : Fresenius announces issuance of equity-neutral convertible bonds . To issue 500 million eur convertible bonds due 2024 . Convertible bonds to have issue price 100 percent to 104.75 percent, conversion premium 45 percent . Bond to be used to finance Quironsalud, Spain's largest private hospital operator . Says to purchase call options on Fresenius shares to hedge high replayment obligation risk . Initial price to be determined after market close Feb 2, 2017 .Says to apply for bonds to be included in open market segment of Frankfurt Stock Exchange.  Full Article

Fresenius says Fresenius Helios receives antitrust approval to acquire Quirónsalud
Thursday, 22 Dec 2016 11:31am EST 

Fresenius SE & Co KGaA : Fresenius Helios receives antitrust approval from Spanish antitrust authority to acquire Quirónsalud .Closing of transaction expected by January 31, 2017.  Full Article

Fresenius, FMC to focus on IFRS reporting standard, drop U.S. GAAP
Thursday, 1 Dec 2016 03:04am EST 

Fresenius Se : Says will focus on ifrs reporting starting fiscal year 2017 . Says will then no longer provide u.s. Gaap financial information . Says will focus on ifrs reporting and discontinue u.s. Gaap financial statements . Says will focus its reporting on financial statements in accordance with international financial reporting standards (ifrs) in euro currency starting with the 2017 fiscal year on january 1, 2017 .Says discontinuation of u.s. Gaap reporting will not affect the sponsored level 2 american depositary receipt (adr) program of fresenius medical care ag & co. Kgaa in the united states.  Full Article

Fresenius says Q2 adj EBIT up 8 pct
Monday, 1 Aug 2016 05:09pm EDT 

Fresenius Se : Says q2 adj ebit 1,051 million eur . Says q2 sales 7.1 billion eur (+2%, +5% in constant currency) . Says q2 adj net income 393 million eur . Reuters poll average for fresenius q2 sales was 7.16 billion eur, adjusted ebit 1.05 billion, adjusted net income 382 million Further company coverage: [FREG.DE] ((frankfurt.newsroom@thomsonreuters.com; +49 69 7565 1270;)).  Full Article

FMC sticks to guidance after Q2 results
Monday, 1 Aug 2016 04:56pm EDT 

Fresenius Medical Care AG : Says q2 ebit $641 million . Says q2 net income $294 million . Says q2 sales $4,420 million . Reuters poll average for fmc q2 net revenue was $4.44 billion, ebit $634 million, net income $284 million .Says despite unfavorable foreign currency developments and continuous cost pressure, we are confident we will achieve our full year guidance.  Full Article

Fresenius SE & Co KGaA confirms FY 2016 guidance
Monday, 2 May 2016 08:00pm EDT 

Fresenius SE & Co KGaA:Confirms its guidance for FY 2016; Sales are expected to increase by 6 pct to 8 pct in constant currency. Net income is expected to grow by 8 pct to 12 pct in constant currency.  Full Article

More From Around the Web

Fitch Rates Fresenius Finance Ireland Bonds at 'BBB-'; Affirms Fresenius at 'BBB-'

(The following statement was released by the rating agency) LONDON, March 23 (Fitch) Fitch Ratings has assigned Fresenius Finance Ireland PLC's (FFI) EUR2.6 billion guaranteed senior notes an instrument rating of 'BBB-'. It has also affirmed Fresenius Medical Care AG (FMC) & Co. KGaA and Fresenius SE & Co.KGaA's (FSE, together Fresenius) Long-Term Issuer Default Rating at 'BBB-'. The Outlook is Stable. A full list of rating actions is at the end of this commentary. KEY RATING DRIVERS Market